Clinical Nutrition Market Size, Share & Trends Analysis Report By Route of Administration (Oral, Enteral, Parenteral), By Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Malnutrition, Others), By End-User (Pediatric, Adults, Geriatric) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Market Overview

The global clinical nutrition market size was valued at USD 34.82 billion in 2021. It is projected to reach USD 60.35 billion by 2030, growing at a CAGR of 6.3% during the forecast period (2022–2030).

 A clinical nutrition product is a form of medicine that helps a patient's health. It aids in improving the metabolic system by providing required supplements such as minerals, vitamins, and other nutrients. Clinical nutrition is concerned with diagnosing and treating illnesses that affect food intake, intestinal absorption, and metabolism and promoting health by preventing diet-related diseases. It is employed in various contexts, including cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.

The demand for clinical nutrition is increasing as chronic and lifestyle-related diseases such as inflammatory bowel disease and diabetes mellitus rise. Furthermore, the growing geriatric population and government R&D investments in the healthcare sector also contribute to market growth. Advances in clinical nutrition are also increasing. Additionally, rising demand for clinical nutrition in emerging markets such as Asia-Pacific and Latin America, as well as an increase in the use of nutritional products in-home care, will likely provide attractive prospects for global clinical nutrition participants.

Market Dynamics

Global Clinical Nutrition Market Drivers

Rising Incidences of Chronic and Lifestyle-Associated Disease

The growing prevalence of chronic and life-associated diseases drives the growth of the market in clinical nutrition. According to the WHO, 60% of related factors to individual health and quality of life are correlated to lifestyle, and millions of people follow an unhealthy lifestyle. Problems like metabolic diseases, joint and skeletal issues, cardiovascular diseases, hypertension, overweight, and violence can be caused by an unhealthy lifestyle. Several other disorders require clinical nutrition care, such as anorexia, cachexia, food allergy, and intolerance of disaccharides. Individuals suffering from these syndromes often have nutritional deficiency problems. In recent years, a significant rise in the incidence rate of nutritional problems has been witnessed across the globe. For example, according to the American Society of Parenteral and Enteral Nutrition, around 150,000 infants and hospitalized patients receive nutrition support annually in the US.

Furthermore, chronic gastrointestinal (GI) diseases such as peptic ulcers, food allergy, constipation, diverticulosis, inflammatory bowel disease, and colon cancer commonly result in malnutrition and morbidity. This will boost the market for clinical nutrition. According to the WHO, four of every ten adults worldwide suffer from functional gastrointestinal disorders of varying severity. A rise in the number of nutrition-related diseases globally is anticipated to drive the market for clinical nutrition shortly.

Growing Geriatric Population

The growing geriatric population globally is driving the growth of the global market of clinical nutrition. As with age, people become less active, their metabolism slows, and their energy requirement decreases because older adults' ability to absorb and utilize nutrients becomes less efficient. Therefore, their nutrient requirements increase. According to the WHO, the proportion of the world's population over 60 years will nearly double from 12% in 2015 to 22% in 2050.

Furthermore, as per the World Aging Population Report, there will be approximately 727 million people aged 65 and above, many of whom are susceptible to chronic diseases and digestive problems, necessitating surgery. For example, in July 2020, Goodmills Innovation released "Spermidino EVO," wheat germ extracts designed to improve immunity in the elderly population. As a result, the market of clinical nutrition is likely to rise in the near future amid the growing older population and the development of clinical nutrition products tailored to the needs of the elderly.

Global Clinical Nutrition Market Restraint

Lack of Awareness for Clinical Nutrition

Though the surge in demand for clinical nutrition is on the rise, a lack of awareness regarding healthcare and diet has been witnessed. Individuals are unaware of the availability of clinical nutrition, and this lack of understanding can be noticed in developed and developing countries. Deficiencies and disorders are seen mainly because of a lack of the proper knowledge of vitamins and nutrition and the availability of wrong information. Unfortunately, education and direct support for health and hygiene are not up to the required level. Therefore, many campaigns have been conducted to promote awareness regarding the clinical nutrition benefits for different diseases. However, there is still a lack of understanding regarding clinical nutrition for various illnesses. Consequently, this lack of awareness of clinical nutrition is anticipated to hamper the market.

Global Clinical Nutrition Market Opportunities

Underlying Growth Opportunities in Emerging Economies

The emerging economies of the Asia-Pacific and LAMEA regions offer lucrative growth opportunities for the clinical nutrition due to improved healthcare infrastructure and increased demand for better healthcare. In addition, the rise in the incidence of various lifestyle and chronic diseases that develop a problem of malnutrition and dietary issues and growth in the research required for the development of medical devices for clinical nutrition of various illnesses such as respiratory, renal, and cancer, have boosted the demand for the clinical nutrition market.

Furthermore, an increase in the geriatric population with a lack of nutrition is driving the growth of the market for clinical nutrition. According to the Global Data article, in 2020, Asia-Pacific accounted for the maximum number of older adults, roughly 226 million. Additionally, the surge in healthcare reforms in developing nations is anticipated to offer remunerative opportunities for market expansion. An increase in healthcare and R&D investments in developing countries such as India, China, and Brazil also boosts the market growth.

Regional Analysis

Region-wise, the global clinical nutrition market share is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America holds the leading position in the market and is estimated to grow at a CAGR of 5.5% during the forecast period. Continuous R&D toward creating new clinical nutrition is a prominent trend in the North American clinical nutrition industry. In addition, for various chronic conditions such as coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. The incidence of diabetes has increased the demand for medical nutrition therapy. Furthermore, the rising demand for clinical nutrition in the pediatric industry will likely provide attractive growth possibilities for market players. The large proportion of preterm newborns in emerging economies is to blame.

Asia-Pacific is the fastest-growing region. The significant factors accrediting the growth of the Asia Pacific market in clinical nutrition include an increase in the prevalence of metabolic disorders and neurological diseases, a rise in the geriatric population in the Asia Pacific Region, and high spending on healthcare. Furthermore, rise in government initiatives for the improvement of the healthcare sector and a surge in the focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high growth opportunities in the market. 

Europe is the second-largest region. The European market of clinical nutrition is projected to reach USD 17,325 million by 2030, growing at a CAGR of 6.2%. The alarming increase in nutrition therapy and dietary therapy for patients diagnosed with metabolic syndrome is a significant driver of the clinical nutrition market in this region. In addition, a rise in awareness among patients in European countries regarding the availability of clinical nutrition is anticipated to boost the market growth. Moreover, an increase in government support for innovation and a rise in funding of projects for R&D of innovative clinical nutrition further fuel the market growth in this region.

Segmental Analysis

The global clinical nutrition market share is segmented by the route of administration, application, end-user, and region. 

Based on route of administration, the global market is classified into Oral, Enteral, and Parenteral.

The Oral route of administration holds the highest market share and is estimated to grow at a CAGR of 5.7% during the forecast period. The oral nutritional supplement is widely used in acute and community health settings for individuals unable to meet their dietary requirements through oral diet alone. Further, an increase in incidences of chronic diseases provides lucrative growth opportunities for the oral clinical nutrition market.

The Enteral route of administration is the fastest-growing segment. The increase in the prevalence of chronic disorders such as cancer and neurological disorders is the primary factor contributing to the growth of the enteral nutrition market. Furthermore, the growing geriatric population, rising malnutrition cases, technical enhancements, and inclusion of proper ingredients into the composition of products will drive the market growth. 

Based on application, the global market is categorized into Cancer, Neurological Diseases, Gastrointestinal Disorders, and Others.

The Gastrointestinal Disorders segment is the highest contributor to the market and is estimated to grow at a CAGR of 5.6% during the forecast period. According to the World Health Organization (WHO), gastrointestinal reflux diseases account for approximately 8 million deaths per year worldwide. In the US, it is estimated that about 60 to 70 million citizens are affected annually. Moreover, mainly the liver and pancreas diseases, such as food allergy, disaccharidase intolerance, and gluten-sensitive enteropathy, need clinical nutrition. Companies such as Nestlé S.A. provide gastrointestinal nutrition products. Further, the surge in many clinical trials for gastrointestinal disorders offers a lucrative opportunity for gastrointestinal effects during the forecast period.

The Cancer segment is the fastest growing. This is attributed to the side effects of cancer affecting normal eating and nutrition in the body. Furthermore, nutritional deficiency is a common medical problem that affects around 15–40% of cancer patients. Nutrition therapy helps cancer patients keep healthy body weight, maintain strength, keep body tissue healthy, and decrease side effects during and after treatment.

Based on end-user, the global market share is segmented into Pediatric, Adult, and Geriatric.

The Pediatric segment is the largest shareholder and is estimated to grow at a CAGR of 7% during the forecast period. The increasing rate of pre-mature births is also projected to boost market growth within the forecast period. Furthermore, major players such as Nestle S.A. and Abbott Laboratories sell products for children with special needs. An increasing number of products to serve pediatric patients with growing awareness about such diseases is expected to boost the market's growth.

Geriatrics is the second largest segment. The geriatric population is susceptible to several chronic diseases due to a lack of nutritional intake through food. This is expected to contribute to the growth of the market for clinical nutrition during the forecast period. Moreover, the increasing prevalence of sarcopenia, weakness, organ dysfunction, low immunity, and osteoporosis are a few other factors. People suffering from chronic conditions such as cancer and diabetes coupled with the growing geriatric population are also anticipated to supplement the market growth.

Recent Developments

• April 2022 - Baxter International Inc., a leader in patient monitoring, physical assessment, and vision screening products, announced the findings of an observational study on data from the Starling Registry. The Baxter-sponsored research found that monitoring stroke volume and cardiac output trends for patients with critical conditions may provide insight into cardiac function and help predict patient outcomes, including mortality.

• May 2022 - Abbott announced that the United States District Court for the Western District of Michigan had amended the recent consent decree, allowing Abbott to release limited quantities of its EleCare® specialty amino acid-based formulas that were previously on hold following the recall of some powder infant formulas from its Sturgis, Mich., facility on February 17th. Abbott and the US Food and Drug Administration (FDA) requested that the consent decree be altered to allow the business to get EleCare to children in urgent medical need. According to an agreement with the FDA, several EleCare product batches were put on hold.